Trial
NCT06397144
A Study on 2 Different Combination Tablets of Nirmatrelvir Plus Ritonavir to Compare Them With Marketed Paxlovid in Healthy Participants
Phase IWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Pfizer
Collaborators
—
Condition
Biological Availability
Intervention
Paxlovid
Why stopped
Sponsor business decision to terminate study. Decision not due to major safety concerns or requests from any regulatory authorities.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-12-26